Correlation Between Coherus BioSciences and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Coherus BioSciences and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coherus BioSciences and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coherus BioSciences and Cue Biopharma, you can compare the effects of market volatilities on Coherus BioSciences and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coherus BioSciences with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coherus BioSciences and Cue Biopharma.
Diversification Opportunities for Coherus BioSciences and Cue Biopharma
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Coherus and Cue is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Coherus BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coherus BioSciences are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Coherus BioSciences i.e., Coherus BioSciences and Cue Biopharma go up and down completely randomly.
Pair Corralation between Coherus BioSciences and Cue Biopharma
Given the investment horizon of 90 days Coherus BioSciences is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Coherus BioSciences is 1.23 times less risky than Cue Biopharma. The stock trades about -0.02 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 192.00 in Cue Biopharma on August 25, 2024 and sell it today you would lose (90.00) from holding Cue Biopharma or give up 46.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Coherus BioSciences vs. Cue Biopharma
Performance |
| Timeline |
| Coherus BioSciences |
| Cue Biopharma |
Coherus BioSciences and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coherus BioSciences and Cue Biopharma
The main advantage of trading using opposite Coherus BioSciences and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coherus BioSciences position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Coherus BioSciences vs. Assembly Biosciences | Coherus BioSciences vs. Spero Therapeutics | Coherus BioSciences vs. Achilles Therapeutics PLC | Coherus BioSciences vs. Instil Bio |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |